Skip to main content
. Author manuscript; available in PMC: 2021 May 3.
Published in final edited form as: Int J Infect Dis. 2021 Jan 10;104:465–470. doi: 10.1016/j.ijid.2020.12.085

Figure 1. Proportion of participants with different study outcomes.

Figure 1.

The panels show data for the 64 participants at screening (Panel A) and at month 12 (Panel B). HIV drug resistance testing was only performed for participants with viral loads >400 copies/mL. The proportion of participants with drug resistance in each group is shown for all participants; participants who were virally suppressed were classified as having no drug resistance. Abbreviations: ARV, antiretroviral; VL, viral load; and mL, milliliter.